UBC Medical Indonesia Past Earnings Performance

Past criteria checks 4/6

UBC Medical Indonesia has been growing earnings at an average annual rate of 34%, while the Healthcare industry saw earnings growing at 0.07% annually. Revenues have been growing at an average rate of 9.3% per year. UBC Medical Indonesia's return on equity is 2.8%, and it has net margins of 2.5%.

Key information

34.05%

Earnings growth rate

10.84%

EPS growth rate

Healthcare Industry Growth	14.15%
Revenue growth rate	9.28%
Return on equity	2.75%
Net Margin	2.54%
Last Earnings Update	31 Mar 2025

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How UBC Medical Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

IDX:LABS Revenue, expenses and earnings (IDR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 25	152,358	3,873	47,091
31 Dec 24	147,637	2,952	47,803
31 Dec 23	136,699	2,190	48,720
31 Dec 22	93,292	2,834	33,758
31 Dec 21	129,960	308	46,240

Quality Earnings: LABS has a high level of non-cash earnings.

Growing Profit Margin: LABS's current net profit margins (2.5%) are higher than last year (1.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: LABS's earnings have grown significantly by 34% per year over the past 5 years.

Accelerating Growth: LABS's earnings growth over the past year (62.8%) exceeds its 5-year average (34% per year).

Earnings vs Industry: LABS earnings growth over the past year (62.8%) exceeded the Healthcare industry 5%.

Return on Equity

High ROE: LABS's Return on Equity (2.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/27 04:26
End of Day Share Price	2025/05/27 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT UBC Medical Indonesia Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.